Abstract
This study sought to investigate the effect of β-caryophyllene (BCP) on sexual performance, crucial enzymes linked to erectile function as well as lipid peroxidation in the penile tissue of paroxetine (PD)-induced rats. Animals were randomly divided into ten groups of five animals each: normal control (NC), BCP (10 mg/kg), BCP (20 mg/kg), sildenafil citrate (SD) (20 mg/kg), BCP + SD (20 mg/kg), PD (20 mg/kg), PD + BCP (10 mg/kg), PD + BCP (20 mg/kg), PD + SD (20 mg/kg) and PD + BCP (20 mg/kg) + SD (20 mg/kg). Oral administration of 20 mg/kg body weight of PD for the first 7 days was done while treatment with BCP and SD were performed between 8 and 14 days prior to euthanasia. The sexual performance study revealed that PD caused erectile dysfuction. Elevated activities of phosphodiesterase-5′ (PDE-5′), arginase, adenosine deaminase (ADA), acetylcholinesterase (AChE) and angiotensin-I converting enzyme (ACE) as well as lipid peroxidation level were observed in PD-induced rats when compared to the NC group. However, treatment with sildenafil and/ or β-Caryophyllene significantly reduced the activities of AChE, PDE-5′, arginase, ADA, and ACE in penile tissues of PD-induced rats. In addition, co-administration of β-caryophyllene and sildenafil citrate showed better modulatory effects. Thus, β-caryophyllene could represent a potential nutraceutical in the management of erectile dysfunction.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The mechanism of penile erection involves a haemodynamic process in the cavernosal tissues and nervous system [1]. Erectile dysfunction (ED) results from the inability to attain and maintain erection needed for sexual satisfaction [1, 2]. It is associated with pathological and physiological changes in the corpus cavernosal tissues [2]. In addition, ED has been linked to several pathological conditions such as hypercholesterolemia, hypertension, cardiovascular diseases and diabetes [3, 4]. Studies have also shown that depression as well as the use of antidepressant drugs may lead to ED [5, 6]. However, drugs such as sildenafil or sildenafil citrate, vardenafil, and tadalafil, are currently in use for the treatment of ED [7, 8]. These drugs possess attendant side effects including dizziness, blurred vision, nasal congestion, hearing loss, dyspepsia, nasopharyngitis, myalgia [8, 9]. Sildenafil citrate, a PDE-5′ inhibitor, acts by inhibiting PDE-5, an enzyme that promotes degradation of CGMP thus enhancing the attainment of penile rigidity [9].
For effective management and treatment of ED, therapeutic options should exceed the use of PDE-5 inhibitors [10]. There are indications that some crucial enzymes such as arginase, acetylcholinesterase (AChE) and adenosine diaminase (ADA), linked to biomolecules such as cGMP, NO, ACh and adenosine involved in penile erection, could be therapeutic targets [10, 11]. Considering the vast range of bioactivity and broad spectrum of specificity of plants, bioactive compounds in plants may represent safe, natural, alternative and effective therapeutics or therapeutic sources for the treatment of erectile dysfunction [11, 12]. Holistic treatment of ED may actually involve elevation in nitric oxide (NO) production, repair of endothelial dysfunction, enhancement of antioxidant status, as well as increase in the levels of cyclic-guanosine monophosphate (cGMP), acetylcholine (ACh) and adenosine in the cavernosal tissue [12, 13].
Beta-caryophyllene (BCP) is a natural, volatile, bicyclic sesquiterpene lactone compound abundantly present as an essential oil component of many dietary and edible plants including spices [14]. Previous studies have also demonstrated the antioxidant, antimicrobial, anticancer, anti-inflammatory, anti-arthritic, cardio protective, anticholinesterase effects in vitro and in vivo [15,16,17,18,19,20]. There is dearth of information on the erectogenic effects of BCP, and the possible mechanisms of BCP in ED. Therefore, this study was convened to assess the effect of β-caryophyllene on sexual performance, lipid peroxidation and crucial enzymes linked to erectile function in penile tissue of paroxetine-induced rats.
Materials and methods
Chemicals, reagents and equipment
5,5-Dithio-bis-(2-nitrobenzoic acid), trichloroacetic acid, thiobarbituric acid (TBA), β-caryophyllene (purity 98.5%), tween 80, acetylthiocholine iodide, and adenosine were purchased from Sigma–Aldrich (St. Louis, MO, USA). Sodium dodecyl sulphate and acetic acid were sourced from BDH Chemicals Ltd, (Poole, England). Other chemicals and reagents used were of analytical grade and water was glass distilled. Kenxin refrigerated centrifuge Model KX3400C and UV–vis spectrophotometer (Model 6305; Jenway, Barloworld Scientific, Dunmow, United Kingdom) were used for centrifuging and the measurement of the absorbance respectively.
Bioassay
Animal ethics
All the animals received humane care according to the criteria outlined in the guide for the care and use of laboratory animals prepared by the National Academy of Science and published by the National Institute of Health (USA). The animal ethic committee of the Federal University of Technology, Akure, Nigeria gave an approval for the use of laboratory animals with reference number of FUTA/ETH/2019/012. The ethic regulations are in accordance with national and institutional guidelines for the protection of animals’ welfare during experiments.
Experimental design
50 Male and 50 female Wistar rats weighing 185–210 g were purchased from the Department of Veterinary Medicine, University of Ibadan, Nigeria. The rats were acclimatized for a period of 2 weeks. The animals were kept in wire mesh cages under controlled light cycle (12 h light/12 h dark). They were fed with commercial growers and water was administered ad libitum. After 2 weeks of acclimatization, the male animals were randomly divided into ten groups (n = 5 in each group);
Group I Normal control rats—was administered the vehicle (1% ethanol).
Group II β-caryophyllene (10 mg/kg).
Group III β-caryophyllene (20 mg/kg).
Group IV Sildenafil citrate (20 mg/kg/day).
Group V β-caryophyllene (20 mg/kg/day) + sildenafil citrate (20 mg/kg/day).
Group VI Paroxetine induced erectile dysfunction (PD) rat.
Group VII Paroxetine induced erectile dysfunction + β-caryophyllene (10 mg/kg).
Group VIII Paroxetine induced erectile dysfunction + β-caryophyllene (20 mg/kg).
Group IX Paroxetine induced erectile dysfunction + sildenafil citrate (20 mg/kg/day).
Group X Paroxetine induced erectile dysfunction + β-caryophyllene (20 mg/kg/day) + sildenafil citrate (20 mg/kg/day).
Paroxetine was administered orally for the first 7 days, after which the rats were treated with the vehicle (1% ethanol), β-caryophyllene, and sildenafil citrate orally for the next 7 days based on their respective groups. The doses of β-caryophyllene (10 and 20 mg/kg/day), paroxetine (20 mg/kg) and sildenafil (20 mg/kg) used were in accordance with previous investigation with slight modification [21, 22]. On the 7th and 14th day only, the female rats were introduced into the cages of the male rat for the sexual performance assays (male paired with female in a single cage) according to the modified method of Thawatchai et al. [23]. The animals were subjected to euthanasia, after been anaesthetized with isoflurane. The penile tissues were excised, rinsed in ice-cold normal saline, blotted and weighed for subsequent analysis.
Sexual performance study
The sexual performance study was carried out according to the modified method of Thawatchai et al. [23]. In order to access the sexual behaviours, estrous female rats was paired with male rats of each group. The female rats were induced with progesterone (1 mg/kg body weight) and estradiol benzoate (10 µg/mg body weight) at 4 and 24 h respectively, injected via intraperitoneal and subcutaneous route respectively) before copulation. Sexual performance was monitored inside a clear rectangular plastic chamber (60 cm length × 40 cm breath × 30 cm height) and recorded using digital video recording on the 7th and 14th day of the experiment, in a quiet room for 1 h. Mounting number, which is the number of mounts without intromission from the time of introduction of the female to the male; mounting latency, which is the time of introduction of the female to the first mount by the male; intromission number, which is the number of intromission form the introduction of the female until the end of the experiment); and intromission latency, which is the interval from the time of introduction of the female to the first intromission by the male, were subsequently determined [24].
Biochemical analysis
Acetylcholinesterase (AChE) inhibitory assay
A mixture of penile tissue homogenate (200 μL), 5,5′-dithio-bis-(2-nitrobenzoic) acid [3.3 mM, 100 μL) and 0.1 M phosphate buffer (pH 8.0) was incubated for 20 min at 25 °C, after which acetylthiocholine iodide was added. The absorbance of the mixture was measured at 412 nm immediately after the addition of the substrate [25]. AChE activity was calculated with respect to the total protein. The specific activity of AChE was expressed as µmol. AChE/h/mg protein.
Phosphodiesterase-5 (PDE-5) activity assay
The penile tissue was prepared with 0.1 M Tris–HCl buffer containing 1 mM CaCl2 and 50 mM NaCl (pH 8.0). The reaction mixture containing 5 mM of the substrate (p-nitrophenyl phenylphosphonate), penile homogenate, 20 mM Tris buffer (pH 8.0), was incubated at 37 °C for 10 min. The intensity of p-nitrophenol produced was measured as change in absorbance after 5 min at 400 nm [26]. The specific activity of PDE-5 was calculated and expressed as µmol./min/mg protein.
Arginase activity assay
In brief, the arginase activity in penile homogenate was firstly activated by adding Tris–HCl (75 μL, 50 mmol/l, pH 7.5) containing 10 mmol/l MnCl2, which was preincubated for 10 min at body temperature, followed by catalyzing the L-arginine by arginase by incubating the mixture containing activated arginase, L-arginine (50 μL, 0.5 mol/l, pH 9.7) 1 h. This was halted by adding 400 μL of the acid solution mixture [H2SO4/H3PO4/H2O at ratio 1:3:7 (v/v/v)]. For the development of urea concentration, α-isonitrosopropiophenone (25 μL 9% in absolute ethanol) was then added and the mixture was heated at 100 °C for 45 min [27]. The urea concentration was determined spectrophotometrically at 550 nm measured the amount of urea produced, after normalization with protein, was used as an index for arginase activity.
Adenosine deaminase (ADA) activity
Briefly, 50 μL of penile tissue homogenate reacted with 21 mmol/L of adenosine, pH 6.5, and was incubated at 37 °C for 60 min. The protein content used for the experiment was adjusted to between 0.7 and 0.9 mg/mL [28]. Results were expressed in units per liter (U/L). One unit (1 U) of ADA is defined as the amount of enzyme required to release 1 mmol of ammonia per minute from adenosine at standard assay conditions.
Angiotensin-I converting enzyme (ACE) assay
The ACE activity was carried out according to the method described by Cushman and Cheung [29] with slight modification. The penile tissue homogenate was pre-incubated at 37 °C for 15 min. The ACE substrate [150 μL, 8.33 mM hippuryl-l-histidyl-leucine in 125 mM of Tris − HCl buffer (pH 8.3)] was added to the mixture, which was incubated at 37 °C for 30 min. The reaction was halted with 250 μL of 1 M HCl. The enzymatic product [hippuric acid (Bz-Gly)] was extracted with 1.5 mL of ethyl acetate, and centrifuged to separate the ethyl acetate layer. Thereafter, 1 mL of ethyl acetate layer was transferred to a clean test tube and evaporated to dryness. Distilled water (1 mL) was added and its absorbance was measured at 228 nm. The specific activity of ACE was calculated with respect to the total protein and reported as μmol./min/ mg protein.
Lipid peroxidation assay
Lipid peroxidation was determined as the formation of thiobarbibutric acid-reactive substances (TBARS) during an acid heating reaction according to the method of Ohkawa et al. [30]. Briefly, the reaction mixture consisting of 200 μL of the penile homogenates or standard (0.03 mM malondialdehyde (MDA)), 200 μL of 8.1% sodium dodecyl sulfate (SDS), 500 μL of 0.8% TBA, and 500 μL of acetic acid solution (2.5 M HCl, pH 3.4) was heated at 95 °C for 1 h. The absorbance was measured at 532 nm, and the penile tissue lipid peroxidation levels were expressed as micromoles MDA per milligram of protein.
Statistical analysis
All data were expressed as the means ± standard error of mean (SEM). One-way ANOVA was used for the statistical analysis followed by the post hoc Tukey’s test; p < 0.05 was considered to represent a significant difference using Prism software (GraphPad, version 6.0, Carlsbad, CA, USA).
Results
As shown in Tables 1 and 2, the results of mounting and intromission latencies as well as mounting and intromission frequencies on the 7th day of experiment revealed that there was significant (p < 0.05) increase in mounting and intromission latencies as well as significant (p < 0.05) reduction in mounting and intromission frequencies of PD group when compared with NC group. In a similar manner, there was significant (p < 0.05) elevation in both mounting and intromission latencies and significant (p < 0.05) decrease in mounting and intromission frequencies in PD group as compared to the NC group on the 14th day (Table 1). However, mounting and intromission latencies were significantly (p < 0.05) reduced in PD rat groups administered BCP (10 and 20 mg/kg), SD (20 mg/kg) and combination of BCP (20 mg/kg) and SD (20 mg/kg) in comparison to PD control group (Table 1). Conversely, treatment of PD rats with BCP (10 and 20 mg/kg), SD (20 mg/kg) and combination of BCP (20 mg/kg) and SD (20 mg/kg) showed significant (p < 0.05) increase in mounting and intromission frequencies (Table 2).
As presented in Fig. 1, the effects of BCP, SD as well as the combination of BCP and SD on AChE activity in penile tissues of NC and PAR-induced rats were determined. A significant (p < 0.001) increase in AChE activity of PD group in comparison to the NC group was observed. However, there was decrease in AChE activity in PD rat groups treated with BCP (10 mg/kg), BCP (20 mg/kg) and SD (20 mg/kg) when compared with PD group. Interestingly, treatment with the combination of BCP (20 mg/kg) and SD (20 mg/kg) in PD rats showed significant (p < 0.05) reduction in AChE activity as compared with PD group.
In this study, significant (p < 0.01) elevation in PDE-5 activity of PD rat group and significant (p < 0.05) decrease in PDE-5 activity of SD group in comparison with NC group were observed (Fig. 2). In addition, the administration of BCP (20 mg/kg) and SD (20 mg/kg) in PD rats caused significant (p < 0.05) reduction in PDE-5′ activity as compared to PD rat group (Fig. 2). Furthermore, the result depicts that the combined treatment of PD rats with BCP and SD significantly (p < 0.01) decreased PDE-5′ activity in comparison to the PD group (Fig. 2).
The result of the effect of BCP on arginase activity in penile tissues of paroxetine induced erectile dysfunction in rats is presented in Fig. 3. Arginase activity was significantly (p < 0.01) higher in PD group when compared with NC group. However, there was significant reduction in arginase activity of PD rat groups administered BCP (20 mg/kg) and SD (20 mg/kg) (p < 0.05) and the combination of BCP (20 mg/kg) and SD (20 mg/kg) (p < 0.01) in comparison to PD control group (Fig. 3).
As shown in Fig. 4, there was significant (p < 0.05) decrease in ADA activity of penile tissues in rats treated with SD and combination of BCP and SD when compared with NC group. ADA activity was significantly (p < 0.01) higher in PD group as compared to NC group. Significant reduction in ADA activity of PD rats treated with BCP (20 mg/kg) (p < 0.05), SD (20 mg/kg) (p < 0.01), and the combination of BCP (20 mg/kg) and SD (20 mg/kg) (p < 0.01) in comparison to PD rat group was observed.
Figure 5 reveals the effect of SD, BCP and their combination on ACE activity in penile tissues of normal and paroxetine-induced rats. The activity of ACE was significantly (p < 0.01) elevated in PD rat group when compared with NC group. Furthermore, PD rat groups treated with BC (10 mg/kg) (p < 0.05), BCP (20 mg/kg) and SD (20 mg/kg) and combination of BCP (20 mg/kg) and SD (20 mg/kg) had significantly (p < 0.05) lower ACE activity in comparison to the PD group.
Figure 6 depicts a significant (p < 0.01) increase in the level of lipid peroxidation (LPO) of PD rat group when compared with NC group. However, the administration of BCP (10 & 20 mg/kg), SD (20 mg/kg) and both BCP (20 mg/kg) and SD (20 mg/kg) in PD rats caused significant (p < 0.01) reduction in LPO level as compared to PD group (Fig. 6). Normal rats treated with SD and BCP + SD had significantly (p < 0.05) lower LPO in comparison to the NC group (Fig. 6).
Figure 7 reveals the histological representative micrographs of rat penile tissue (corpus cavernosum). Control rats show intact penile erectile tissues with large vascular cavernous spaces as well as regularly arranged connective tissue fibres and smooth muscles. Numerous endothelial cells lines cavernous spaces were seen. Fatty (adipose) infiltration into erectile tissues indicated by numerous empty cellular structures are obvious in PD rat groups (PIED). Additionally, the connective tissue fibres and smooth muscles were loosely arranged in PD rat group. Furthermore, PD rat groups treated with BC, SD and the combination of BCP and SD, showed near normal erectile tissues (Table 3).
Discussion
Endothelial dysfunction is a crucial underlying factor for ED and vascular disease [3, 22]. Release of NO is central to the induction of smooth muscle cell relaxation, maintenance of vascular endothelial cells, inhibition of vascular smooth muscle proliferation and activation of soluble guanylate cyclase, thus resulting in lower intracellular calcium levels and vasodilatation [31]. Paroxetine is a selective serotonin reuptake inhibitors (SSRIs), that is often used to treat a wide range of depressive, anxiety, and other psychiatric disorders, with good therapeutic results [32, 33]. However, paroxetine has been reported to cause sexual dysfunction [34]. Erectile dysfunction in human subjects and animals have been associated with impairment in erection, oxidative degradation of penile tissues [3, 31]. Hence, there is continuous search for safe, natural and effective therapeutic agents from several phytochemicals from plant sources [19]. Plant phytochemicals have been reported to modulate pathophysiological pathways linked to ED [19, 35]. Considering the various biological properties of BCP, it is regarded as a multifunctional and polypharmacological agent for therapeutic development in complex diseases [21, 36, 37]. The mechanisms of sexual behavior involve initiation (arousal component), an intromission count, hit rate and copulation. The observed increase in both mounting and intromission latencies (Table 1) of PD group suggest that certain form of sexual dysfunction has occurred [38]. The decreased mounting and intromission latencies observed in PD rat groups administered BCP (10 and 20 mg/kg), SD (20 mg/kg) and combination of BCP (20 mg/kg) and SD (20 mg/kg) indicates the restoration of the desire for sex thus enhancing sexual behavior [38]. Furthermore, reduction in mounting and intromission frequencies (Table 2) in PD group noticed in this study support previous assertions that paroxetine; an antidepressant drug could cause sexual dysfunction and lower copulation in male rats [22, 32,33,34]. The observed increase in mounting and intromission frequencies of PD rats treated with BCP (10 and 20 mg/kg), SD (20 mg/kg) and the combination of BCP (20 mg/kg) and SD (20 mg/kg) could be attributed to possible enhancement of copulation and erectogenic efficiency of β-caryophyllene, sildenafil and their combination [39, 40]. Reduction in mounting and intromission latencies as well as elevation of mounting and intromission frequencies in rats with erectile dysfunction by β-caryophyllene, sildenafil and their combination agree with previous investigation where prophylactics and/or plant phytochemicals were reported to enhance sexual function in male rats [41,42,43].
Modulation in the activities of critical enzymes such as AChE, PDE-5, arginase, ADA, ACE, and oxidative stress index (lipid peroxidation) in penile tissues are crucial therapeutic strategies towards the management/treatment of endothelial dysfunction and erectile dysfunction [10, 36, 37]. In this study, elevation in AChE activity observed in PD group may be connected to erectile dysfunction. Increased AChE activity depletes acetylcholine level in penile tissues thus causing impairment of penile or sexual function [22]. Acetylcholine; a neurotransmitter which is a key determinant in the regulation of erection and improvement of erectile function via its action on vascular endothelium, which induces the release of NO and elevates cGMP [10, 36]. The reduction in AChE activity of rats treated with the combination of β-Caryophyllene (20 mg/kg/day) and sildenafil (20 mg/kg/day) in PD-Induced rats in this study indicate decreased degradation of acetylcholine in the penile tissues by β-Caryophyllene and sildenafil. This suggests that β-caryophyllene and sildenafil are promising and effective therapeutic agents for the management of anti-depressant-induced erectile dysfunction [44]. The result is in agreement with earlier reports from our laboratory on the inhibitory effect of plant phytochemicals on penile and heart AChE in vivo [22, 37, 44]. The combination of BCP and SD in PD-induced ED showed better reductive effect on AChE activity as compared to treatment with BCP or SD. This could be attributed to the mechanism of action of SD as a strong PDE-5′ inhibitor and not a specific inhibitor of AChE [9, 22]. Hence, the use of SD may not effectively improve erectile function in ED cases related to the reduction of acetylcholine or high AChE activity [22].
The use of PDE-5′ inhibitors has been established as an effective strategy for the treatment of antidepressant-induced ED in men [38, 44]. In this study, the administration of PD led to a significant increase in PDE-5′ activity in rats’ penile tissues. The observed increase in the activity of PDE-5′ in PD group may be linked with impairment in erectile function [9]. Elevated PDE-5 activity has been demonstrated to cause rapid degradation of cGMP, which can hinder the processes involved in penile erection. Thus, cGMP plays a major role in the erectile process as it triggers penile erection [35]. It induces the activation of cGMP-dependent protein kinase, which reduces calcium levels and trigger the relaxation of smooth muscles, contraction of the penile veins and rigidity of penile erection [2]. High PDE-5′ activity may indicate low levels of cGMP in the corpus cavernosum [45]. In this study, SD (20 mg/kg), BCP (20 mg/kg) and the combination of BCP and SD significantly reduced PDE-5′ activity in penile tissues of PD-induced rats. The observed inhibitory effects suggest that BCP are potent inhibitors of PDE-5′ activity. This indicates that BCP and SD could prevent rapid degradation of cGMP levels in corpus cavernosum of penile tissues, hence inducing the relaxation of smooth muscles and improving erectile process in antidepressant-induced ED [20]. The result suggests that BCP may show effective potentials in improving erectile function in anti-depressant-induced sexual dysfunction. The combination of BCP and SD in PD induced ED showed better inhibitory effect on PDE-5′ activity in comparison with treatment with either BCP or SD. Furthermore, the side effects associated with the use of sildenafil limit its use hence BCP may represent a safe and effective therapy that could reduce the side effects associated with SD [46].
The L-arginine-nitric oxide-guanylyl cyclase-cyclic guanosine monophosphate pathway is very important in the mechanism of penile erection [47]. The availability of NO is important to the erectile process [47]. Moreover, in the erectile tissue, NO is produced from L-arginine and oxygen in a reaction regulated by NO synthase. In the normal erectile process, sexual arousal stimulates the release of NO which penetrates into the smooth muscle cells and binds to guanylyl cylase thereby changing its conformation to form cGMP—an intracellular trigger of penile erection [31]. However, in ED cases, arginase competes with NO synthase to reduce the availability of NO in the endothelial cells [37, 48]. Findings from this study revealed that the administration of PD increased arginase activity in rat penile tissues. This indicates that antidepressants caused elevation in the activity of arginase, an enzyme that hinder the relaxation of smooth muscle cavernosal tissues and reduction of NO levels. However, treatment with BCP and SD reduced arginase activity in penile tissues of PD-induced rats. Our findings showed that BCP effectively reduced arginase activity in penile tissues of PD-induced rats as much as SD. The combination of BCP and SD in PD induced ED showed better inhibitory effect on arginase activity than treating with either BCP or SD in PD induced ED. The implication of this result is that administration of BCP may reduce the availability of NO as much as that of SD. In addition, BCP are not selective only for PDE-5′ but exhibit multiple inhibitory effects on different enzymes linked to ED. However, our findings suggest that the combinatorial effects of both BCP and SD showed better therapeutic action on arginase activity.
The administration of PD increased the activity of ADA in PD-induced rats. The observed increase in ADA activity in PD-induced rats could be associated with the alteration of adenosine signaling. Alteration of adenosine signaling has been linked with impairment in erectile function [11]. Adenosine acts as a neuromodulator in the corpus cavernosum, hence causing smooth muscle relaxation of penile tissues [11, 49]. ADA regulates adenosine levels in corpus cavernosal tissues by breaking it down to inosine [50]. However, the increase in ADA activity may deplete adenosine levels in the corpus cavernosum and impair penile erection. Our findings revealed that treatment with SD and BCP (20 mg/kg) reduced ADA activity in PD-induced rats. The combinatorial effects of BCP and SD showed better inhibitory action against ADA activity when compared to the treatment with either BCP or SD in PD induced ED. The observed decrease in ADA activity could be attributed to the interaction of the flavonoids with the enzyme. Previous report has shown that compounds such as carotenoids, quercetin, myricetin, naringin and kaempferol are potent inhibitors of ADA [51]. Although, the possible mechanism of action involved in the inhibition of ADA has not been fully understood, however there are indications that the hydroxyl groups of some of these flavonoids may interact with the active site of the enzyme, hence reducing the activity of the enzyme [51]. This finding suggests that BCP may alleviate the impairment of erectile function in anti-depressant-induced ADA by improving adenosine signaling in penile tissues.
Evidence has shown that ACE is involved in mechanisms involving penile erection via the regulation of angiotensin II (Ang II) levels in corpus cavernosal tissues [52]. ACE converts Ang I to Ang II and degrades bradykinin in the renin-angiotensin system (RAS). Ang II is a vasoconstrictor produced at physiological levels in the endothelial cells of the human corpus cavernosal tissues [53]. However, high levels of Ang II have been associated with the pathogenesis of ED. In this study, the administration of PD led to an increase in ACE activity in PD induced rats, which correlates with rapid conversion of Ang I to Ang II with concomitant increase in the levels of Ang II. Experimental investigations have shown that Ang II may induce smooth muscle cell contraction [53, 54] and elicit harmful effects such as fibrosis, proliferation and oxidative damage to corpus cavernosal tissues by binding to angiotensin II receptor type I (AT1). However, our findings revealed that treatment with SD and BCP (10 and 20 mg/kg) led to a significant decrease in ACE activity in PD-induced rats. The significant reduction of ACE activity observed in PD-induced rats treated with BCP indicates reduction in vasoconstriction necessitated by AngII. Moreover, treatment with BCP showed significant reduction in ACE activity compared to SD. The combination of BCP and SD in PD induced ED showed better inhibitory effect on ACE activity than treating with either BCP or SD in PD induced ED. This finding suggests that the use of BCP may be an effective strategy for the treatment of erectile dysfunction associated with hypertension.
Oxidative stress has been implicated as one of the factors involved in the pathogenesis of ED [55]. Lipid peroxidation is an important oxidative stress biomarker that has been identified in cavernosal tissues of ED patients [1]. Malondialdehyde (MDA) is a veritable index of lipid peroxidation [56]. The observed elevation in MDA levels in rats’ penile tissues could be attributed to increased oxidative damage to the penile tissue. This implies that administration of PD may aggravate free radicals release that will accelerate the destruction of the penile tissues and membrane lipid peroxidation. However, the observed decrease in MDA level in PD rats treated with BCP, SD and the combination of BCP and SD, could be attributed to the antioxidant properties of BCP and SD, which include free radical scavenging ability, ferric reducing power, iron chelating ability and donation of hydrogen. The observed non-significant difference in MDA production between the PD rats treated with either BCP or SD or the combination of BCP and SD may indicate possible safety in the use of BCP, SD or the combination of BCP and SD.
As observed in the histological architectures of the penile tissues (Fig. 7), fatty infiltration into erectile tissues as well as the loosely arranged connective tissue fibres and smooth muscles are indicative of erectile dysfunction in PD rats. Paroxetine, being one of the commonest selective serotonin reuptake inhibitors (SSRIs) often used, has been associated with damage to penile tissues due to oxidative insults, thus affecting the penile cell structural components (mainly proteins and lipid). Hence, the observed adipose tissue infiltration seen in PD group. This corroborates the assertion that excessive intake of paroxetine may cause erectile dysfunction [34]. However, BCP attenuated the PD induced erectile dysfunction in rat as shown by the intact nature of the penile tissues in BCP and SD treated PD rats. This could be attributed to the possible enzyme modulation and antioxidant properties of BCP and/ or SD. From this study, β-Caryophyllene and sildenafil significantly modulate the activities of critical enzymes (phosphodiesterase-5′, arginase, acetylcholinesterase, adenosine deaminase and Angiotensin-I converting enzyme) and lipid peroxidation (malondialdehyde), in penile tissues of paroxetine-induced erectile dysfunction in rats. The combination of BCP and SD in PD induced ED showed better reductive effect on critical enzymes activity than treating with BCP or SD alone in PD induced ED. This could be possible mechanisms by which BCP and/or SD alone attenuate PD induced erectile dysfunction in rats. Further studies in animal models at the molecular level are required to substantiate these findings.
References
Biri TH, Onaran M et al (2003) Cavernosal tissue nitrite, nitrate, malondialdehyde and glutathione levels in diabetic and non-diabetic erectile dysfunction. Int J Androl 26:250–254
Dean RC, Lue TF (2005) Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am 32:379–395
Bivalacqua TJ, Usta MF, Champion HC et al (2003) Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl 24:S17–S37. https://doi.org/10.1002/j.1939-4640.2003.tb02743.x
Silva FH, Veiga FJR, Mora AG et al (2017) A novel experimental model of erectile dysfunction in rats with heart failure using volume overload. PLoS ONE 12:0187083
Werneke U, Northey S, Bhugra D (2006) Antidepressants and sexual dysfunction. Acta Psychiatr Scand 114:384–397
Rajfer J, Aronson WJ, Bush PA et al (1992) Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission, New England. J Med Surg Collat Branches Sci 326:90–94
Tostes RC, Giachini FR, Carneiro FS et al (2007) Determination of adenosine effects and adenosine receptors in murine corpus cavernosum. J Pharm Exp Ther 322:678–685
Yang R, Wang J, Chen Y et al (2008) Effect of caffeine on erectile function via up-regulating cavernous cyclic guanosine monophosphate in diabetic rats. J Androl 29:586–591
Huang SA, Lie JD (2013) Phosphodiesterase-5 (PDE5) inhibitors in the management of erectile dysfunction. Pharm Ther 38(7):407–419
Naylor AM (1998) Endogenous neurotransmitters mediating penile erection. Br J Urol 81:424–431
Phatarpekar PV, Wen J, Xia Y (2010) Role of adenosine signaling in penile erection and erectile disorders. J Sex Med 7:3553–3564
Adefegha SA, Oboh G, Oyeleye SI et al (2017) Erectogenic, antihypertensive, antidiabetic, anti-oxidative properties and phenolic compositions of almond fruit (Terminalia catappa L.) parts (hull and drupe)—in vitro. J Food Biochem 41:e12309
Adefegha SA, Oboh G, Maduka BO et al (2017) Comparative effects of alkaloid extracts from Alligator pepper (Aframomum melegueta) and Bastered melegueta (Aframomum danielli) on enzymes relevant to erectile dysfunction. J Diet Suppl 14:542–552
Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M, Zimmer A (2008) Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA 105:9099–9104
Calleja MA, Vieites JM, Montero-Meléndez T, Torres MI, Faus MJ, Gil A, Suárez A (2013) The antioxidant effect of β-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation. Br J Nutr 109:394–401
Klauke AL, Racz I, Pradier B, Markert A, Zimmer AM, Gertsch J, Zimmer A (2014) The cannabinoid CB2 receptor-selective phytocannabinoid beta caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain. Eur Neuropsychopharmacol 24:608–620
Dahham SS, Tabana YM, Iqbal MA, Ahamed MB, Ezzat MO, Majid AS, Majid AM (2015) The anticancer, antioxidant and antimicrobial properties of the sesquiterpene β-caryophyllene from the essential oil of Aquilaria crassna. Molecules 20:11808–11829
Agarwal RB, Rangari VD (2003) Phytochemical investigation and evaluation of anti-inflammatory and anti-arthritic activities of essential oil of Strobilanthus ixiocephala Benth. Indian J Exp Biol 41:890–894
Younis NS, Mohamed ME (2019) β-Caryophyllene as a potential protective agent against myocardial injury: the role of toll-like receptors. Molecules 24:1929. https://doi.org/10.3390/molecules24101929
Charu S, Juma MA, Syed MN, Sameer NG, Mohammad AK, Shreesh O (2016) Polypharmacological properties and therapeutic potential of β-caryophyllene: a dietary phytocannabinoid of pharmaceutical promise. Curr Pharm Des 22:1–28
He J, Zhou S, Li X, Wang C, Yu Y, Chen X, Lu Y (2017) Pharmacokinetic evaluation of β-caryophyllene alcohol in rats and beagle dogs. Xenobiotica 48:845–850
Adefegha SA, Oyeleye SI, Dada FA, Olasehinde TA, Oboh G (2018) Modulatory effect of quercetin and its glycosylated form on key enzymes and antioxidant status in rats’ penile tissue of paroxetine-induced erectile dysfunction. Biomed Pharmacother 107:1473–1479
Thawatchai P, Jintanaporn W, Sitthachai I, Supaporn M, Wipawee T (2012) Moringa olifera leaves extract attenuates male sexual dysfunction. Am J Neurosci 3:17–24
Ferraz MMD, Quntella SL, Parcial ALN, Ferraz MR (2016) The effects of sildenafil after chronic L-NAME administration in male rat sexual behaviour. Pharmacol Biochem Behav 146:13–20
Perry NS, Bollen C, Perry EK et al (2003) Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav 75:651–659
Kelly SJ, Butler LG (1977) Enzymic hydrolysis of phosphonateesters. Reaction mechanism of intestinal 50-nucleotide phosphodiesterase. Biochemistry 16:1102–1104
Zhang C, Hein TW, Wang W et al (2001) Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide-mediated vasodilatory function. FASEB J 15:1264–1266
Guisti G, Galanti B (1984) Colorimetric method. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Verlag Chemie, Weinheim, pp 315–323
Cushman DW, Cheung HS (1971) Spectrophotometric assay and properties of the Angiotensin I converting enzyme of rabbit lung. Biochem Pharmacol 20:1637–1648
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358
Andersson KE (2011) Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharmacol Rev 63:811–859
Montejo-Gonzales AL, Llorca G, Izquierdo JA, Ledesma A, Bousono M, Calcedo A (1997) SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 23:176–194
Osis L, Bishop JR (2010) Pharmacogenetics of SSRIs and sexual dysfunction. Pharmaceuticals 3:3614–3628
Higgins A, Nash M, Lynch AM (2010) Antidepressant-associated sexual dysfunction: impact, effects, and treatment. Drug Healthc Patient Saf 2:141–150
Burnett AL (2008) Molecular pharmacotherapeutic targeting of PDE5 for preservation of penile health. J Androl 29:3–14
Jung J, Jo HW, Kwon H, Jeong NY (2014) Clinical neuroanatomy and neurotransmitter-mediated regulation of penile erection. Int Neurourol J 18:58–62
Adefegha SA, Oyeleye SI, Oboh G (2018) African crocus (Curculigo pilosa) and Wonderful kola (Buchholzia coracea) seeds modulate critical enzymes relevant to erectile dysfunction and oxidative stress. J Complement Integr Med 15(4). https://doi.org/10.1515/jcim-2016-0159
Outhoff K (2009) Antidepressant-induced sexual dysfunction. South Afr Fam Pract 51:298–302
Yakubu MT, Akanji M, Oladiji AT (2007) Male sexual dysfunction and method used in assessing medical plant with aphrodisiac potential. Pharmacogn Rev 1:49–56
Adefegha SA, Oboh G, Oyeleye SI, Ejakpovi I (2016) Erectogenic, antihypertensive, antidiabetic, antioxidative properties and phenolic compositions of Almond Fruit (Terminalia catappa L.) Parts (Hull and Drupe)—in vitro. J Food Biochem 41:e12309
Halliwell B (2007) Dietary polyphenols: good, bad, or indifferent for your health? Cardiovasc Res 73:341–347
Scalbert A, Manach C, Morand C et al (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45:287–306
Eleazu C, Obianuju N, Eleazu K, Kalu W (2017) The role of dietary polyphenols in the management of erectile dysfunction–mechanisms of action. Biomed Pharmacother 88:644–652
Baldwin DS, Palazzo MC, Masdrakis VG (2013) Reduced treatment-emergent sexual dysfunction as a potential target in the development of new antidepressants. Depress Res Treat 25:68–41
Corbin JD (2004) Mechanisms of action of PDE5 inhibition in erectile dysfunction. Int J Impot Res 16(Suppl 1):S4–S7. https://doi.org/10.1038/sj.ijir.3901205
Kenia P, Clinton N (2012) Mechanisms in erectile function and dysfunction: an overview, erectile dysfunction. Disease-Associated Mechanisms and Novel Insights into Therapy, pp 1–22
Michl U, Molfenter F, Graefen M et al (2015) Use of phosphodiesterase type 5 inhibitors may adversely impact biochemical recurrence after radical prostatectomy. J Urol 193:479–483
Olabiyi AA, Oboh G, Adefegha SA (2017) Effect of dietary supplementation of tiger nut (Cyperus esculentus L.) and walnut (Tetracarpidium conophorum müll. Arg.) on sexual behavior, hormonal level, and antioxidant status in male rats. J Food Biochem 41:e12351
Sebastiao AM, Ribeiro JA (2000) Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci 21:341–346
Leal CAM, Leal DBR, Adefegha SA et al (2016) Effects of chlorogenic acid on adenine nucleotides hydrolyzing enzyme activities and expression in platelets of rats experimentally demyelinated with ethidium bromide. Biomed Pharmacother 81:363–370
Li G, Nakagome I, Hirono S et al (2015) Inhibition of adenosine deaminase (ADA)-mediated metabolism of cordycepin by natural substances. Pharmacol Res Persp 3:e00121
Fraga-Silva RA, Montecucco F, Mach F (2013) Pathophysiological role of the renin–angiotensin system on erectile dysfunction. Eur J Clin Invest 43:978–985
Park JK, Kim SZ, Kim SH et al (1997) Renin angiotensin system in rabbit corpus cavernosum: functional characterization of angiotensin II receptors. J Urol 158:653–658
Jin LM (2009) Angiotensin II signaling and its implication in erectile dysfunction. J Sex Med 6:302–310
Agarwal A, Nandipati KC, Sharma RK et al (2006) Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction. J Peritoneum 27:335–347
Valko M, Leibfritz D, Moncol J et al (2007) Free radicals and antioxidants in normalphysiological functions and human disease. Int J Biochem Cell Biol 39:44–84
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to disclose.
Rights and permissions
About this article
Cite this article
Adefegha, S.A., Oboh, G. & Olopade, E.O. β-caryophyllene improves sexual performance via modulation of crucial enzymes relevant to erectile dysfunction in rats. Toxicol Res. 37, 249–260 (2021). https://doi.org/10.1007/s43188-020-00061-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43188-020-00061-2